Rethinking Growth in Pharma: Intelligent Engagement, Unified Data, and the New Commercial Playbook
The New Rules of Pharma Marketing in a Privacy‑First World The old campaign-centric model of outreach no longer delivers in a marketplace defined by specialty therapies, complex access, and discerning healthcare professionals (HCPs). Today’s pharma marketing must be precise, evidence-led, and coordinated across channels while honoring the realities of consent and compliance. Meaningful growth hinges